Cargando…
Anti-Galectin-2 Antibody Treatment Reduces Atherosclerotic Plaque Size and Alters Macrophage Polarity
Background Galectins have numerous cellular functions in immunity and inflammation. Short-term galectin-2 (Gal-2) blockade in ischemia-induced arteriogenesis shifts macrophages to an anti-inflammatory phenotype and improves perfusion. Gal-2 may also affect other macrophage-related cardiovascular di...
Autores principales: | Kane, Jamie, Jansen, Matthijs, Hendrix, Sebastian, Bosmans, Laura A., Beckers, Linda, Tiel, Claudia van, Gijbels, Marion, Zelcer, Noam, Vries, Carlie J. de, von Hundelshausen, Philipp, Vervloet, Marc, Eringa, Ed, Horrevoets, Anton J., Royen, Niels van, Lutgens, Esther |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251707/ https://www.ncbi.nlm.nih.gov/pubmed/34852377 http://dx.doi.org/10.1055/a-1711-1055 |
Ejemplares similares
-
Stimulation of Collateral Vessel Growth by Inhibition of Galectin 2 in Mice Using a Single‐Domain Llama‐Derived Antibody
por: Hollander, Maurits R., et al.
Publicado: (2019) -
CD40 in coronary artery disease: a matter of macrophages?
por: Jansen, Matthijs F., et al.
Publicado: (2016) -
Atherosclerotic Plaque Destabilization in Mice: A Comparative Study
por: Hartwig, Helene, et al.
Publicado: (2015) -
Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques
por: Baardman, Jeroen, et al.
Publicado: (2020) -
Dendritic Cells in Human Atherosclerosis: From Circulation to Atherosclerotic Plaques
por: Van Vré, Emily A., et al.
Publicado: (2011)